Back to Browse Journals » International Journal of Nanomedicine » Volume 7
Nanoscale modification of porous gelatin scaffolds with chondroitin sulfate for corneal stromal tissue engineering
Authors Lai JY, Li YT, Cho CH, Yu TC
Received 1 December 2011
Accepted for publication 20 January 2012
Published 23 February 2012 Volume 2012:7 Pages 1101—1114
DOI https://doi.org/10.2147/IJN.S28753
Review by Single-blind
Peer reviewer comments 4
Jui-Yang Lai*, Ya-Ting Li*, Ching-Hsien Cho, Ting-Chun Yu
Institute of Biochemical and Biomedical Engineering, Chang Gung University, Taoyuan, Taiwan, Republic of China
*These authors contributed equally to this work
Abstract: Recent studies reflect the importance of using naturally occurring biopolymers as three-dimensional corneal keratocyte scaffolds and suggest that the porous structure of gelatin materials may play an important role in controlling nutrient uptake. In the current study, the authors further consider the application of carbodiimide cross-linked porous gelatin as an alternative to collagen for corneal stromal tissue engineering. The authors developed corneal keratocyte scaffolds by nanoscale modification of porous gelatin materials with chondroitin sulfate (CS) using carbodiimide chemistry. Scanning electron microscopy/energy dispersive X-ray spectroscopy and Fourier transform infrared spectroscopy showed that the amount of covalently incorporated polysaccharide was significantly increased when the CS concentration was increased from 0% to 1.25% (w/v). In addition, as demonstrated by dimethylmethylene blue assays, the CS content in these samples was in the range of 0.078–0.149 nmol per 10 mg scaffold. When compared with their counterparts without CS treatment, various CS-modified porous gelatin membranes exhibited higher levels of water content, light transmittance, and amount of permeated nutrients but possessed lower Young’s modulus and resistance against protease digestion. The hydrophilic and mechanical properties of scaffolds modified with 0.25% CS were comparable with those of native corneas. The samples from this group were biocompatible with the rabbit corneal keratocytes and showed enhanced proliferative and biosynthetic capacity of cultured cells. In summary, the authors found that the nanoscale-level modification has influence on the characteristics and cell-material interactions of CS-containing gelatin hydrogels. Porous membranes with a CS content of 0.112 ± 0.003 nmol per 10 mg scaffold may hold potential for use in corneal stromal tissue engineering.
Keywords: corneal keratocyte, carbodiimide chemistry, porous gelatin membranes, stroma
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Other articles by this author:
Stabilization of collagen nanofibers with l-lysine improves the ability of carbodiimide cross-linked amniotic membranes to preserve limbal epithelial progenitor cells
Lai JY, Wang PR, Luo LJ, Chen ST
International Journal of Nanomedicine 2014, 9:5117-5130
Published Date: 5 November 2014
Glutaraldehyde cross-linking of amniotic membranes affects their nanofibrous structures and limbal epithelial cell culture characteristics
Lai JY, Ma DH
International Journal of Nanomedicine 2013, 8:4157-4168
Published Date: 31 October 2013
Biodegradable in situ gelling delivery systems containing pilocarpine as new antiglaucoma formulations: effect of a mercaptoacetic acid/N-isopropylacrylamide molar ratio
Lai JY
Drug Design, Development and Therapy 2013, 7:1273-1285
Published Date: 24 October 2013
Readers of this article also read:
Prevalence of distorted body image in young Koreans and its association with age, sex, body weight status, and disordered eating behaviors
Hong SC, Jung YE, Kim MD, Lee CI, Hyun MY, Bahk WM, Yoon BH, Lee KH
Neuropsychiatric Disease and Treatment 2015, 11:1043-1049
Published Date: 9 April 2015
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system
Ribeiro TG, Chávez-Fumagalli MA, Valadares DG, Franca JR, Rodrigues LB, Duarte MC, Lage PS, Andrade PHR, Lage DP, Arruda LV, Abánades DR, Costa LE, Martins VT, Tavares CAP, Castilho RO, Coelho EAF, Faraco AAG
International Journal of Nanomedicine 2014, 9:877-890
Published Date: 14 February 2014
Erratum
Marusza W, Mlynarczyk G, Olszanski R, Netsvyetayeva I, Obrowski M, Iannitti T, Palmieri B
International Journal of Nanomedicine 2012, 7:4119-4120
Published Date: 27 July 2012
Corrigendum
Chen ZQ, Liu Y, Zhao JH, Wang L, Feng NP
International Journal of Nanomedicine 2012, 7:1709-1710
Published Date: 30 March 2012
Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting
Xie F, Yao N, Qin Y, Zhang Q, Chen H, Yuan M, Tang J, Li X, Fan W, Zhang Q, Wu Y, Hai L, He Q
International Journal of Nanomedicine 2012, 7:163-175
Published Date: 6 January 2012
Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex
Zhang J, Peng Q, Shi S, Zhang Q, Sun X, Gong T, Zhang Z
International Journal of Nanomedicine 2011, 6:3405-3414
Published Date: 19 December 2011
Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells
An YL, Nie F, Wang ZY, Zhang DS
International Journal of Nanomedicine 2011, 6:3187-3194
Published Date: 6 December 2011
Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo
Feng L, Wu H, Ma P, Mumper RJ, Benhabbour SR
International Journal of Nanomedicine 2011, 6:2545-2556
Published Date: 21 October 2011
Evaluation of injectable silica-embedded nanohydroxyapatite bone substitute in a rat tibia defect model
Xu W, Ganz C, Weber U, Adam M, Holzhüter G, Wolter D, Frerich B, Vollmar B, Gerber T
International Journal of Nanomedicine 2011, 6:1543-1552
Published Date: 2 August 2011
Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation
Shahrooz Saremi, Fatemeh Atyabi, Seyedeh Parinaz Akhlaghi, et al
International Journal of Nanomedicine 2011, 6:119-128
Published Date: 12 January 2011
